Risk of bacterial contamination from citrate catheter locks

Seminars in Dialysis

Volumn 22, Issue 6, 2009, Pages 704-

  Stranz, Marc ^a   Hadaway, Lynn ^b  

^a Field Clinical Services   (United States)

^b Lynn Hadaway Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CITRATE SODIUM; CITRIC ACID; HEPARIN;

CENTRAL VENOUS CATHETERIZATION; CROSS INFECTION; EQUIPMENT; GRAFT OCCLUSION; HUMAN; INDWELLING CATHETER; INSTRUMENTATION; LETTER; RENAL REPLACEMENT THERAPY;

ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CITRATES; CROSS INFECTION; EQUIPMENT CONTAMINATION; GRAFT OCCLUSION, VASCULAR; HEPARIN; HUMANS; RENAL DIALYSIS;

EID: 71549173178     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2009.00685.x     Document Type: Letter

References (8)

1. Moran JE, Ash SR, ASDIN Clinical Practice Committee : Locking solutions for hemodialysis catheters; heparin and citrate - a position paper by ASDIN. Semin Dial 21 : 490 492, 2008
2. Weijmer MC, Debets-Ossenkopp YJ, van der Vondervoort FJ, ter Wee PM : Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 17 : 2189 2195, 2002
3. Lok CE, Appleton D, Bhola C, Khoo B, Richardson RM : Trisodium citrate 4%: an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant 22 : 477 483, 2007
4. MacRae JM, Dojcinovic I, Djurdjev O, Jung B, Shalansky S, Levin A, Kiaii M : Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS). Clin J Am Soc Nephrol 3 : 369 374, 2008
5. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Health Care Infection Control Practices Advisory Committee : Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 35 (10 Suppl. 2 S65 S164, 2007
6. Trissel LA, Gentempo JA, Saenz LM, Woodard MY, Angeles CH : Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations. Am J Health Syst Pharm 64 : 837 841, 2007
7. Hutin Y, Hauri A, Chiarello L, Catlin M, Stilwell B, Ghebrehiwet T, Garner J, the Members of the Injection Safety Best Practices Development Group : Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections. Bull World Health Organ 81 : 491 500, 2003
8. USP : <797> Guidebook to Pharmaceutical Compounding - Sterile Preparations. Rockville, MD : US Pharmacopeial Convention, Inc., 2008